This trial is active, not recruiting.

Conditions abdominal aortic aneurysm, aorto-iliac aneurysm
Treatment iliac leg graft
Sponsor Cook
Start date March 2012
End date March 2016
Trial size 600 participants
Trial identifier NCT01540643, 11-015


The purpose of this registry is to obtain case reports of physician experience with the Spiral-Z® graft under routine clinical care.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model cohort
Time perspective prospective
iliac leg graft
Zenith® Spiral-Z® AAA Iliac Leg Graft

Primary Outcomes

Assess short term and longer term outcomes, including outcomes related to patency, of the Zenith® Spiral-Z® AAA Iliac Leg Graft.
time frame: 12 months

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Patient is implanted with Zenith® Spiral-Z® AAA Iliac Leg Graft. Exclusion Criteria: - Patients for whom this device would not normally be considered standard of care.

Additional Information

Official title Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry
Principal investigator Thomas Lindsay
Trial information was received from ClinicalTrials.gov and was last updated in November 2016.
Information provided to ClinicalTrials.gov by Cook.